Dendritic cell-based vaccines in treating recurrent herpes labialis: Results of pilot clinical study

References

• Stanberry L, Cunningham A, Mindel A, Scott L, Spruance S, Aoki F, Lacey C. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 2000; 30:549-66; PMID:10722443; http://dx.doi.org/10.1086/313687
   PubMed Web of Science ®Google Scholar
• Sancho-Shimizu V, Perez De Diego R, Jouanguy E, Zhang S, Casanova J. Inborn errors of anti-viral interferon immunity in humans. Curr Opin Virol 2011; 1:487-96; PMID:22347990
   PubMed Web of Science ®Google Scholar
• Van Lint A, Ayers M, Brooks A, Coles R, Heath W, Carbone F. Herpes simplex virus-specific CD8+ T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J Immunol 2004; 172:392-97; PMID:14688347; http://dx.doi.org/10.4049/jimmunol.172.1.392
   PubMed Web of Science ®Google Scholar
• Zhu J, Peng T, Johnston C, Phasouk K, Kask A, Klock A. Immune surveillance by CD8-α,α+ skin-resident T cells in human herpes virus infection. Nature 2013; 497:494-97; PMID:23657257; http://dx.doi.org/10.1038/nature12110
   PubMed Web of Science ®Google Scholar
• McKenna D, Neill W, Norval M. Herpes simplex virus specific immune responses in subjects with frequent and infrequent orofacial recrudescences. Br. J. Dermatol 2001; 144:459-64; PMID:11259999; http://dx.doi.org/10.1046/j.1365-2133.2001.04068.x
   PubMed Web of Science ®Google Scholar
• Mysliwska J, Trzonkowski P, Bryl E, Lukaszuk K, Mysliwski A. Lower interleukin-2 and higher serum tumor necrosis factor levels are associated with perimenstrual, recurrent, facial herpes simplex infection in young women. Eur Cytokine Netw 2000; 11:397-406; PMID:11022124
   PubMed Web of Science ®Google Scholar
• Zheltova O, Starostina N, Tikhonova M, Leplina O, Chernykh E, Ostanin A. Immunity features of patients with chronic recurrent infections. Immunology 2011; 4:205-9. (Russian).
   Google Scholar
• Cunningham A, Griffiths P, Leone P, Mindel A, Patel R, Stanberry L, Whitley R. Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol 2012; 53(1):6-11; PMID:21889905
   PubMed Web of Science ®Google Scholar
• Rooney J, Straus S, Mannix M, Wohlenberg C, Alling D, Dumois J, Notkins A. Oral acyclovir to suppress frequently recurring herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med 1993; 18:268-72; PMID:8380540; http://dx.doi.org/10.7326/0003-4819-118-4-199302150-00004
   PubMed Web of Science ®Google Scholar
• Chi C, Wang S, Delamere F, Wojnarowska F, Peters M, Kanjirath P. Interventions for prevention of herpes simplex labialis (cold sores on the lips). Cochrane Database Syst Rev 2015; 8:CD010095, doi: 10.1002/14651858; PMID:26252373
   PubMedGoogle Scholar
• BenMohamed L, Bertrand G, McNamara C, Gras-Masse H, Hammer J, Wechsler S, Nesburn A. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity. J Virol 2003; 77:9463-73; PMID:12915561; http://dx.doi.org/10.1128/JVI.77.17.9463-9473.2003
   PubMed Web of Science ®Google Scholar
• Bettahi I, Zhang X, Afifi R, BenMohamed L. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response. Viral Immunol 2006; 19:220-36; PMID:16817765; http://dx.doi.org/10.1089/vim.2006.19.220
   PubMed Web of Science ®Google Scholar
• Bedoui S, Greyer M. The role of dendritic cells in immunity against primary herpes simplex virus infections. Front Microbiol 2014; 5:533; PMID:25374562; http://dx.doi.org/10.3389/fmicb.2014.00533
   PubMed Web of Science ®Google Scholar
• Lee H, Zamora M, Linehan M, Iijima N, Gonzalez D, Haberman A, Iwasaki A. Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J Exp Med 2009; 206:359-70; PMID:19153243; http://dx.doi.org/10.1084/jem.2008-0601
   PubMed Web of Science ®Google Scholar
• Pollara G, Speidel K, Samady L, Rajpopat M, McGrath Y, Ledermann J, Coffin R, Katz D, Chain B. Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. J Infect Dis. 2003; 187:165-78; PMID:12552441; http://dx.doi.org/10.1086/367675
   PubMed Web of Science ®Google Scholar
• Kobelt D, Lechmann M, Steinkasserer A. The interaction between dendritic cells and herpes simplex virus-1. Curr Top MicrobiolImmunol 2003; 276:145-61; PMID:12797447
   PubMed Web of Science ®Google Scholar
• Bedoui S, Gebhardt T. Interaction between dendritic cells and T cells during peripheral virus infections: a role for antigen presentation beyond lymphoid organs. Curr Opin Immunol 2011; 23:124-30; PMID:21112755; http://dx.doi.org/10.1016/j.coi.2010.11.001
   PubMed Web of Science ®Google Scholar
• Ghasemi M, Erturk M, Buruk K, Sonmez M. Induction of potent protection against acute and latent herpes simplex virus infection in mice vaccinated with dendritic cells. Cytotherapy 2013; 15:352-61; PMID:23579060; http://dx.doi.org/10.1016/j.jcyt.2012.11.012
   PubMed Web of Science ®Google Scholar
• Dhodapkar M, Steinman R, Sapp M, Desai H, Fossella C, Krasovsky J, Donahoe S, Dunbar P, Cerundolo V, Nixon D, et al. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. JClinInvest 1999; 104:173-80; PMID:1041-1546
   PubMed Web of Science ®Google Scholar
• Luo J, Li J, Chen R, Nie L, Huang J, Liu Z, Luo L, Yan X. Autologus dendritic cell vaccine for chronic hepatitis B carriers: A pilot, open label, clinical trial in human volunteers. Vaccine 2010; 28:2497-504; PMID:20117267; http://dx.doi.org/10.1016/j.vaccine.2010.01.038
   PubMed Web of Science ®Google Scholar
• Zabaleta A, D'Avola D, Echeverria I, Llopiz D, Silva L, Villanueva L, Riezu-Boj J, Larrea E, Pereboev A, Lasarte JJ, et al. Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection. Mol Ther Methods Clin Dev 2015; 2:15006; PMID:26029717; http://dx.doi.org/10.1038/mtm.2015.6
   PubMedGoogle Scholar
• García F, Plana M, Climent N, Leon A, Gatell J, Gallart T. Dendritic cell based vaccines for HIV infection: the way ahead. Hum Vaccin Immunother 2013; 9:2445-52.
   PubMed Web of Science ®Google Scholar
• Leplina O, Zheltova O, Borisova A, Starostina N, Ostanin A, Chernykh E. Dendritic cells vaccines in the treatment of herpetic infection. Vestnikural'skoimeditsinskoiakademicheskoinauki 2011; 35:38-39. (Russian).
   Google Scholar
• Della Bella S, Nicola S, Riva A, Biasin M, Clerici M, Villa M. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon–α. J LeukocBiol 2004; 75:106-16; PMID:14525963; http://dx.doi.org/10.1189/jlb.0403154
   PubMed Web of Science ®Google Scholar
• Korthals M, Safaian N, Kronenwett R, Maihofer D, Schott M, Papewalis C, Diaz Blanco E, Winter M, Czibere A, Haas R, et al. Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis. J Transl Med. 2007; 5:46-57; PMID:17894866; http://dx.doi.org/10.1186/1479-5876-5-46
   PubMed Web of Science ®Google Scholar
• Santini S, Pucchini T, Lapenta C, Parlato S, Logozzi M, Belardelli F. A new type 1 IFN-mediated pathway for the rapid differentiation of monocytes into highly active dendritic cells. Stem cells 2003; 21:357-62; PMID:12743330; http://dx.doi.org/10.1634/stemcells.21-3-357
   PubMedGoogle Scholar
• Kabanov V. From synthetic polyelectrolytes to polymer-subunit vaccines. Pure Appl Chem 2004; 76:1659-77; http://dx.doi.org/10.1351/pac200476091659
   Web of Science ®Google Scholar
• Dyakonova V, Dambaeva S, Pinegin B, Khaitov R. Study of interaction between the polyoxidoniumimmu nomodulator and the human immune system cells. IntImmunopharmacol 2004; 4:1615-23; PMID:15454114; http://dx.doi.org/10.1016/j.intimp.2004.07.015
   PubMed Web of Science ®Google Scholar
• Powell B, Andrianov A, Fusco P. Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes. ClinExp Vaccine Res. 2015; 4:23-45; PMID:25648619; http://dx.doi.org/10.7774/cevr.2015.4.1.23
   PubMed Web of Science ®Google Scholar
• Chentoufi A, Zhang X, Lamberth K, Dasgupta G, Bettahi I, Nguyen A, Wu M, Zhu X, Mohebbi A, Buus S, et al. HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D. J Immunol. 2008; 180(1):426-37; PMID:18097044; http://dx.doi.org/10.4049/jimmunol.180.1.426
   PubMed Web of Science ®Google Scholar